IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

Journal of Clinical Investigation

Volumn 117, Issue 6, 2007, Pages 1538-1549

  Sanada, Shoji ^a   Hakuno, Daihiko ^a   Higgins, Luke J ^a   Schreiter, Eric R ^a   McKenzie, Andrew N J ^b   Lee, Richard T ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c Partners Research Facility   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 33; INTERLEUKIN DERIVATIVE; MEMBRANE PROTEIN; PHENYLEPHRINE; PROTEIN ST2; RECOMBINANT INTERLEUKIN 33; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BINDING AFFINITY; BIOMECHANICS; CONTROLLED STUDY; FIBROBLAST; HEART DILATATION; HEART HYPERTROPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART PROTECTION; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ANIMALS; BIOMECHANICS; CARDIOTONIC AGENTS; CELLS, CULTURED; FIBROBLASTS; HUMANS; INTERLEUKINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, CARDIAC; NF-KAPPA B; RATS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 34249882513     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30634     Document Type: Article

References (52)

1. Sadoshima, J., and Izumo, S. 1997. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59:551-571.
2. McKinsey, T.A., and Olson, E.N. 2005. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J. Clin. Invest. 115:538-546. doi:10.1172/JCI200524144.
3. Diez, J., Gonzalez, A., Lopez, B., and Querejeta, R. 2005. Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease. Nat. Clin. Pract. Cardiovasc. Med. 2:209-216.
4. Baudino, T., Carver, W., Giles, W.R., and Borg, T.K. 2006. Cardiac fibroblasts: friend or foe? Am. J. Physiol. Heart Circ. Physiol. 291:H1015-H1026.
5. Grossman, W., Jones, D., and McLaurin, L.P. 1975. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 56:56-64.
6. Weinberg, E.O., et al. 2002. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation. 106:2961-2966.
7. Iwahana, H., et al. 1999. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur. J. Biochem. 264:397-406.
8. Weinberg, E.O., et al. 2003. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation. 107:721-726.
9. Shimpo, M., et al. 2004. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation. 109:2186-2190.
10. Kumar, S., Minnich, M.D., and Young, P.R. 1995. ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J. Biol. Chem. 270:27905-27913.
11. Gayle, M.A., et al. 1996. Cloning of a putative ligand for the T1/ST2 receptor. J. Biol. Chem. 271:5784-5789.
12. Schmitz, J., et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 23:479-490.
13. Manabe, I., Shindo, T., and Nagai, R. 2002. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ. Res. 91:1103-1113.
14. Marian, A.J. 2000. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet. 355:58-60.
15. Goldsmith, E.C., et al. 2004. Organization of fibroblasts in the heart. Dev. Dyn. 230:787-794.
16. Kawano, S., et al. 2005. Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Cardiovasc. Res. 67:689-698.
17. Hirotani, S., et al. 2002. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation. 105:509-515.
18. Townsend, M.J., Fallon, P.G., Matthews, D.J., Jolin, H.E., and McKenzie, A.N. 2000. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 191:1069-1076.
19. Kuster, G.M., et al. 2005. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation. 111:420-427.
20. Shioi, T., et al. 1997. Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ. Res. 81:664-671.
21. Okada, K., et al. 2004. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation. 110:705-712.
22. Yang, G., et al. 2001. Cyclosporine reduces left ventricular mass with chronic aortic banding in mice, which could be due to apoptosis and fibrosis. J. Mol. Cell. Cardiol. 33:1505-1514.
23. Dunne, A., and O'Neill, L.A. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE. 2003:re3.
24. Matsuzawa, A., et al. 2005. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6:587-592.
25. Ninomiya-Tsuji, J., et al. 1999. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 398:252-256.
26. Zhang, D., et al. 2000. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat. Med. 6:556-563.
27. Purcell, N.H., et al. 2001. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 98:6668-6673.
28. Freund, C., et al. 2005. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenolinduced cardiac hypertrophy in vivo. Circulation. 111:2319-2325.
29. Ha, T., et al. 2005. Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload. Cardiovasc. Res. 68:224-234.
30. Hoffmann, A., and Baltimore, D. 2006. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210:171-186.
31. Nelson, D.E., et al. 2004. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science. 306:704-708.
32. Rockman, H.A., Wachhorst, S.P., Mao, L., and Ross, J.J. 1994. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am. J. Physiol. 266:H2468-H2475.
33. Rapacciuolo, A., et al. 2001. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J. Am. Coll. Cardiol. 38:876-882.
34. Ha, T., et al. 2006. Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. Am. J. Physiol. Heart Circ. Physiol. 290:H985-H994.
35. Hingtgen, S.D., et al. 2006. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol. Genomics. 26:180-191.
36. Nishida, M., et al. 2005. G alpha 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. J. Biol. Chem. 280:18434-18441.
37. Li, Q., et al. 2006. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol. Cell. Biol. 26:140-154.
38. Sarkar, S., Vellaichamy, E., Young, D., and Sen, S. 2004. Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. Am. J. Physiol. Heart Circ. Physiol. 287:H107-H117.
39. Saccani, S., Polentarutti, N., Penton-Rol, G., Sims, J.E., and Mantovani, A. 1998. Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo. Cytokine. 10:773-780.
40. May, L.T., Ndubuisi, M.I., Patel, K., and Garcia, D. 1995. Interleukin-6 chaperones in blood. Ann. N. Y. Acad. Sci. 762:120-128.
41. Economides, A.N., et al. 2003. Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat. Med. 9:47-52.
42. Hsieh, P.C., Davis, M.E., Gannon, J., MacGillivray, C., and Lee, R.T. 2006. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Invest. 116:237-248. doi:10.1172/JCI25878.
43. Yokoyama, T., et al. 1999. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am. J. Physiol. 276:H1968-H1976.
44. Yamamoto, K., et al. 1999. Induction of tenascin-C in cardiac myocytes by mechanical deformation. Role of reactive oxygen species. J. Biol. Chem. 274:21840-21846.
45. Hakuno, D., Takahashi, T., Lammerding, J., and Lee, R.T. 2005. Focal adhesion kinase signaling regulates cardiogenesis of embryonic stem cells. J. Biol. Chem. 280:39534-39544.
46. Yamamoto, K., Ohki, R., Lee, R.T., Ikeda, U., and Shimada, K. 2001. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation. 104:1670-1675.
47. Frantz, S., et al. 1999. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104:271-280.
48. Schulze, P.C., et al. 2004. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J. Biol. Chem. 279:30369-30374.
49. Rockman, H.A., et al. 1991. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 88:8277-8281.
50. Tanaka, N., et al. 1996. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 94:1109-1117.
51. Collins, K.A., et al. 2001. Accuracy of echocardiographic estimates of left ventricular mass in mice. Am. J. Physiol. Heart Circ. Physiol. 280:H1954-H1962.
52. Takemoto, M., et al. 1997. Important role of tissue angiotensin- converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J. Clin. Invest. 99:278-287.